We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 32.00 | 1.91% | 1,705.00 | 1,701.00 | 1,701.50 | 1,718.50 | 1,673.00 | 1,685.50 | 5,853,296 | 16:35:27 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.21 | 70.03B |
From May 2021 to May 2024
TIDMGSK
RNS Number : 4366S
GlaxoSmithKline PLC
15 November 2021
BLOCK LISTING SIX MONTHLY RETURN
Date: 15 November 2021
Hot Features
Premium
Name of applicant: GlaxoSmithKline plc
Name of scheme: GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan
--------------------------------------------------------
Period of return: From: 1 May 2021 To: 31 October 2021
------------------------ --------------------- ------ -------------------------
Balance of unallotted securities under scheme(s) from
previous return: 35,519
--------------------------------------------------------
Plus: The amount by which the block scheme(s) has been
increased since the date of the last
return (if any increase has been applied for): 230,000
--------------------------------------------------------
Less: Number of securities issued/allotted under scheme(s)
during period (see LR3.5.7G): 0
--------------------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at
end of period: 265,519
--------------------------------------------------------
Name of applicant: GlaxoSmithKline plc
Name of scheme: GlaxoSmithKline plc Share Save Plan 2012
---------------------------------------------
Period of return: From: 1 May 2021 To: 31 October 2021
------------------------ ----------------- ----- -------------------
Balance of unallotted securities under scheme(s) from previous return: 382,466
---------------------------------------------
Plus: The amount by which the block scheme(s) has been increased since
the date of the last
return (if any increase has been applied for): 3,000,000
---------------------------------------------
Less: Number of securities issued/allotted under scheme(s) during
period (see LR3.5.7G): 313,319
---------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of
period: 3,069,147
---------------------------------------------
Name of contact: Victoria Whyte
Telephone number of contact: 020 8047 5000
---------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BLRFZMMMVKKGMZM
(END) Dow Jones Newswires
November 15, 2021 11:37 ET (16:37 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
